{"id": "1370340748713951233", "creation": 1615549668.0, "user_id": "2900681362", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 8, "reply_count": 3, "like_count": 24, "quote_count": 0}}, "text": "Today with our partner @sanofi, we announced the start of the Phase 1/2 clinical trial for MRT5500, an #mRNA #vaccine candidate against #COVID19. Read the press release: https://t.co/g4Od3jmeyk $TBIO @sanofipasteur https://t.co/pIwtZdAI0n", "first_save": 1634559108.199414, "hashtags": ["#MRNA", "#VACCINE", "#COVID19"]}